NNRX Nutranomics Receives Trademark Approvals for Key Asian

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
NNRX Nutranomics Receives Trademark Approvals for Key Asian Markets

DRAPER, Utah, Nov. 6, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the Company has received trademark approvals for the Nutranomics brand in Japan, Malaysia, and Taiwan.

"Trademarking Nutranomics in important markets like Japan, Malaysia, and Taiwan is a part of our ongoing strategy to distinguish our brand from competitors.  We cannot begin our marketing campaigns until we know our brand is protected," stated Dr. Tracy K. Gibbs, CEO of Nutranomics.  "We are fully committed to leveraging our current MLM private label product development, but we are also excited about expanding our market presence by introducing new and exclusive Nutranomics branded products to distributors and retailers across Asia and in other markets."

Approval of a Nutranomics trademark in Japan, Malaysia, and Taiwan reserves the Company the exclusive right to utilize the trademark on all products and/or services within the specific countries.  The trademark also provides a legal framework to discourage unauthorized use of the Nutranomics name and potential counterfeiting.

Dr. Gibbs concluded, "I anticipate introducing several new Nutranomics branded products throughout the Asian market during 2014."

About Nutranomics

Nutranomics is a publicly traded company engaged in research and development of nutritional food products.  In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public.  Nutranomics has also produced formulas for hundreds of other companies.  Nutranomics' mission is to increase human health and longevity through education and self-awareness.  The Company has sales representatives throughout North America and Asia.

For further information regarding Nutranomics, Inc., please contact our investor relations representatives at ir@nutranomics.com or call toll-free (888) 616-3999.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements."  Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.  Such forward-looking statements include, but are not limited to, the Company potentially expanding its revenue base beyond MLM and introducing several new Nutranomics branded products throughout the Asian market during 2014.  Actual results could differ from those projected in any forward-looking statements due to numerous factors.  Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions.  These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States.  Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.  Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.  These statements have not been evaluated by the Food and Drug Administration.  These products are not intended to diagnose, treat, cure or prevent any disease.

SOURCE Nutranomics, Inc.


Copyright 2013 PR Newswire
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Noble's Q3 2026: A Mixed Bag of Contracts & Losses

Updated Category News Views 86

Noble's Third Quarter: Riding Choppy Waters Sometimes you're up, sometimes you're drowning in red ink. Noble Corporation seemed to catch a bit of both waves this quarter. Contracts: A Silver Lining? The markets felt a jolt with Noble pulling in roughly $560 million in new contracts since July. Not too shabby for a company trying to navigate the muddy waters of today's...

Continue Reading
Post University Expands with New Tech and Health Degrees

Updated Category News Views 56

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Continue Reading
GrOwnValve's Personalized Valves Pass Safety Milestone

Updated Category News Views 102

Pioneering Success in Personalized Valve Study GrOwnValve GmbH just hit a big milestone that's caught my attention. Their first-in-human heart valve study wrapped up its six-month run with no prosthesis-related mishaps. Yeah, zero misfires. For five whole patients who've been through the wringer, things held steady. This Berlin startup’s got guts, testing tech that...

Continue Reading
New Era for Small Cell Lung Cancer: Breakthroughs & Challenges

Updated Category News Views 0

Unpacking Small Cell Lung Cancer Progress These days, it feels like we're standing on the brink of something real big in the fight against small cell lung cancer. And I'm not talking about pie-in-the-sky ideas—there are some serious game changers coming down the pike, folks. You see, in the past, this aggressive cancer type was pretty much a death sentence. But thanks...

Continue Reading
Webull Faces Investor Lawsuit: Compliance in Question

Updated Category News Views 77

Webull's Run into Regulatory Fog Well, here we go—another tech company caught with its pants down over alleged ties with China. Webull Corporation (NASDAQ:BULL) is in the crosshairs of a class action lawsuit. Investors are sharpening their pitchforks, and you've got until December 7, 2026, to throw your hat in the ring as lead plaintiff. The Core of the Allegations...

Continue Reading
Endava Class Action: Investor Concerns Unveiled

Updated Category News Views 88

What's Happened with Endava? Endava plc, trading under NYSE:DAVA, just got pummeled. A lawsuit is making waves, targeting investors who bought into Endava between September 2025 and 2026. What's the fuss about? Their stock tanked 25% on September 22, 2026, following an unsettling revelation: the company disclosed serious management and potential accounting problems. A...

Continue Reading
UFP Industries Fortifies Gulf Coast with $27M Buy

Updated Category News Views 91

UFP Industries Makes a Strategic Move Folks, it looks like UFP Industries (NASDAQ: UFPI) is making some solid moves down in the Gulf Coast, and they're shelling out $27 million to do it. This time, they've got their eyes on Apache Products, dba Acme Skid, a company that's been doing the heavy lifting in the pallet manufacturing space in Silsbee, Texas. Apparently, these...

Continue Reading
Exploring Stillness and Spirituality in Artful Expressions

Updated Category News Views 59

A Different Approach to Mindfulness No two readers will walk away from Ihrie Means' We Come Here For The Flowers with the same experience—that's the beauty of this visual feast. The author's way of blending art with deep, spiritual musings is like a refreshing cup of morning joe, hits you when you least expect it. The book doesn’t throw text-heavy sermons at you;...

Continue Reading
Centerspace Sale Faces Scrutiny Amid Investor Concerns

Updated Category News Views 40

Potential Undervaluation Looms Large over Centerspace Sale On a crisp October day, the saga of Centerspace's proposed sale to Independence Realty Trust (NYSE: IRT) is stirring the pot. Charles C. Foti, Jr., Esq., and the law firm Kahn Swick & Foti, LLC are throwing a wrench into the works, questioning the soundness of the whole shebang. The deal, valued at 3.800 shares of...

Continue Reading
Avoid Costly Insurance Pitfalls: First-Time Homeowner Tips

Updated Category News Views 61

The Missteps of Inexperience You'd think buying a house would make folks pay attention to every stitch and nail, but oddly enough, many first-time homeowners trip over the one thing that's supposed to protect their investment—insurance. It's easy to get off on the wrong foot if you're only eyeing that bottom-line premium figure, missing the forest for the trees. Why...

Continue Reading

Top 5 Most Recently Viewed Articles

Viking M&A Opens New Office in Philadelphia to Support Growth

Updated Category News Views 165

Viking M&A Opens New Office in Philadelphia to Support Growth Viking Mergers & Acquisitions is proud to announce its expansion into Philadelphia, marking a significant milestone as the firm opens its ninth office across the United States. This strategic move is aimed at providing lower middle-market advisory services to the vibrant business community in this key...

Continue Reading
Seasonal Basement Waterproofing Tips from Charlie Hill Expert

Updated Category News Views 91

Seasonal Basement Waterproofing Tips from Charlie Hill Homeowners looking to safeguard their basements from moisture have a valuable resource in Charlie Hill, an expert from Great Lakes Waterproofing. His insights, shared in an article by HelloNation, provide a thorough checklist and practical advice for preventing water damage, especially during the spring thaw....

Continue Reading
Sunshine Biopharma Launches Generic Drug, Stock Prices Soar

Updated Category News Views 155

Sunshine Biopharma's Promising News Shares of Sunshine Biopharma Inc. (NASDAQ:SBFM) have seen a notable rise recently, following the announcement from the pharmaceutical company regarding the launch of a new generic prescription drug. This significant development has sparked interest among investors, as the company aims to capture a portion of the cholesterol-lowering...

Continue Reading
Understanding the Impacts of Options Activity on MongoDB Stocks

Updated Category News Views 139

MongoDB Sees Unusual Options Activity Recent transactions in the options market for MongoDB (NASDAQ: MDB) have drawn attention from financial analysts and investors. A detailed examination reveals 63 unusual trades, indicating a heightened level of interest in the stock, showing a mix of bullish and bearish sentiments. Market Sentiment Analysis Analyzing the data, we find...

Continue Reading
AT&T Transfers Ownership of DIRECTV to TPG Capital

Updated Category News Views 348

AT&T Completes Sale of DIRECTV Stake AT&T has successfully concluded the sale of its entire 70% stake in DIRECTV to TPG Capital. This strategic move showcases AT&T's commitment to optimizing its portfolio and enhancing its focus on core areas of growth in the telecommunications sector. The Transaction with TPG Capital This pivotal transaction marks a significant milestone...

Continue Reading